Table 4 Concerns about care during the first 8 weeks of the national COVID-19 national measures
Belgium (n = 2099) | the Netherlands (n = 2058) | |
|---|---|---|
Concern about availability of medication | ||
Extremely | 3.1 (0–8.5) | 5.5 (0–11.2) |
Very much | 6.1 (0.1–11.4) | 5.8 (0.1–11.5) |
A bit | 23.0 (18.2–27.8) | 21.2 (16.0–26.4) |
No stress | 29.6 (25.0–34.2) | 38.9 (34.3–43.5) |
Not at all | 38.2 (33.9–42.5) | 28.6 (23.7–33.5) |
Concerns about national COVID-19 measures | ||
Extremely | 6.8 (0–15.5) | 12.8 (3.6–22.0) |
Very much | 15.7 (7.4–23.9 | 21.5 (12.8–30.2) |
A bit | 31.0 (23.5–38.5) | 29.0 (20.7–37.3) |
No stress | 22.9 (15.0–30.8) | 21.8 (13.1–30.4) |
Not at all | 23.6 (15.7–31.5) | 15.0 (6.0–24.0) |
Concern about access to care | ||
Extremely | 5.1 (1.0–9.2) | 5.1 (1.0–9.3) |
Very much | 12.2 (8.2–16.2) | 11.7 (7.6–15.8) |
A bit | 35.4 (32.0–38.8) | 34.0 (30.5–37.5) |
No stress | 24.6 (20.9–28.3) | 31.7 (28.1–35.3) |
Not at all | 22.6 (18.8–26.4) | 17.5 (13.6–21.4) |